Hims & Hers to sell Lilly's Zepbound on its telehealth platform
(Reuters) -Telehealth firm Hims & Hers Health said on Tuesday it plans to sell Eli Lilly's diabetes and weight-loss drugs on ...
Eli Lilly weight loss therapy added to Hims & Hers platform (update)
Hims & Hers Health (NYSE:HIMS) stock gains as the company adds Eli Lilly's (LLY) weight loss therapy tirzepatide & generic ...